Oracle's Rebound Masks a Founder's Shrinking Fortune and a Balance Sheet Under Pressure
Published on 08/08/2026 at 15:52 | Redaktion boerse-global.de
The arithmetic of Oracle's current moment is almost surreal. Larry Ellison's personal wealth has reportedly collapsed by roughly $213 billion — from a peak near $388 billion to about $175 billion — as the software giant's shares tumbled by a third over the course of 2026. Yet in the same stretch, the stock just delivered one of its strongest weekly rallies in memory, closing Friday at EUR 127.10, up 12.84% on the week. That split-screen reality — euphoria in the short term, erosion over the long haul — now defines the bull case and the bear case for Oracle in equal measure.
A Chain of Positive Catalysts
The week's surge was powered by a cluster of announcements rather than any single headline. IT services firm CACI International revealed on Monday that it would serve as Oracle's technology partner on a roughly $400 million, ten-year contract with the US Office of Personnel Management to modernize federal HR operations using Oracle Fusion HCM. That same day, reports of an expanded Google Cloud partnership and additional government awards sent the shares up 9.22%.
The Google Cloud tie-up, deepened in late July, will bring Google's Gemini 3.1 Flash-Lite and 3.5 Flash language models into Oracle Fusion Cloud Applications and NetSuite. Oracle followed up on Friday with its "August 2026 Edition" of AI tools, introducing "AI Token Economics" — instruments designed to manage the cost of AI applications — alongside an expanded model selection within OCI Enterprise AI.
Beyond the corporate news, Oracle caught a geopolitical tailwind. President Trump's decision to call off military strikes against Iran and the announcement of fresh negotiations lifted the broader market, and Oracle rode along. The company also pointed to a record cloud backlog of $638 billion, fueled by signals from Microsoft, Amazon, and Samsung about sustained demand for AI infrastructure, plus an expansion of Oracle Health into Ontario hospitals.
The Long Shadow of the Record High
For all the recent momentum, the stock remains 56.89% below its all-time high from September 10, 2025. Friday's close of EUR 127.10 represented a gain of just 2.27% on the day — a reminder that the recovery is still fragile. The gap between the weekly surge and the long-term decline captures the tension at the heart of Oracle's story: a company investing enormous sums into AI infrastructure before those investments pay off, while carrying a debt load that rating agencies and analysts increasingly view with concern.
Workforce Cuts and Credit Concerns
Oracle's latest annual report confirmed a significant reduction in headcount. The global workforce shrank by roughly 21,000 employees — about 13% — to 141,000 in fiscal year 2026. Management attributes the cuts to AI adoption and operational restructuring. For investors, the layoffs are a double-edged signal: they support margins but also underscore the pressure Oracle faces in transforming its business.
As Oracle's restructuring shows, workplace transformation brings new risks alongside new efficiencies. When headcount changes ripple through an organisation, safety documentation often falls behind. A free toolkit with 41 ready-to-use templates helps you keep risk assessments current through periods of change. Download the free Risk Assessment Toolkit
The balance sheet remains the more pressing worry. S&P Global Ratings downgraded Oracle's creditworthiness to BBB- in early July — one notch above junk — citing high debt relative to EBITDA and concentration risks tied to the OpenAI infrastructure agreement. The rating agency's concerns echo across the sector: hyperscalers competing in the AI arms race must front enormous capital before seeing returns.
Wall Street's Wide Divergence
Analyst opinions on Oracle now span an unusually broad range. UBS lowered its price target on Friday from $285 to $245, maintaining a "Buy" rating. Analyst Karl Keirstead pointed to the capital intensity of the AI infrastructure business, return on capital concerns, credit market conditions, and Oracle's dependence on OpenAI. UBS noted that the stock had fallen 27% since the fourth-quarter earnings report, despite strong revenue growth and a robust outlook.
On the same day, Guggenheim reaffirmed its "Buy" rating with a price target of $400 after conversations with Oracle management. That gulf — $245 versus $400 — illustrates just how differently Wall Street assesses the risk profile. Aggregated consensus estimates from recent months reportedly cluster between $248 and $262, blending older and newer assessments.
Motley Fool struck a harsher tone, labeling Oracle the most financially precarious of the major hyperscalers despite the recent rebound, warning that a turn in the AI market would put the stock in serious trouble.
Burry's Bet and the Debt Debate
Adding to the narrative on Friday was the disclosure of a short position by investor Michael Burry, who cited a reference price of $144.63. The filing fueled discussion about rising leverage across the technology sector, though it says little on its own about institutional sentiment. The picture among large investors is mixed: some have built up their Oracle positions substantially, while others have trimmed.
Ellison's Side Bet
Running parallel to Oracle's operational story is a legal one involving its founder. Ellison has provided an irrevocable personal guarantee of $40.4 billion of equity financing for the Paramount Skydance merger with Warner Bros. Discovery, and cannot withdraw assets from the relevant trust during the ongoing proceedings. The Justice Department cleared the deal in June; the EU Commission followed on July 22 with conditions on film distribution in Europe. Twelve state attorneys general, led by California, sued to block the merger, and a federal judge temporarily halted the transaction. On July 24, parties agreed the deal would not close before June 1, 2027, or five days after a decision on the merits. For Oracle shareholders, this is not an operational risk — but it illustrates how closely Ellison's personal engagements are now tied to highly leveraged bets, a pattern mirrored in Oracle's own balance sheet.
What's Next
The next test comes on September 7, when Oracle reports first-quarter fiscal 2027 results. Consensus expects earnings per share of $1.77 on revenue of $19.52 billion. Management has guided for revenue growth of 27% to 29% and cloud revenue growth of 58% to 64%. Whether Oracle hits those marks despite rising investment costs and a growing debt burden will likely determine the stock's next major move. In October, the Oracle AI World conference from October 25-28 will offer another window into the company's AI strategy. Until then, the shares remain a barometer for how long growth promises and balance sheet worries can stay in lockstep.
